Physician profile
Michael J Collins
NPI 1164683744
$2,130.73
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $66.04 · 2021: $201 · 2022: $1,023.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $843.36 | 2019-2021 | |
| Medtronic, INC. | $755.28 | 2021-2022 | |
| Livanova USA, INC. | $190.40 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $123.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $117.33 | 2022 | |
| Getinge USA Sales, LLC | $53.65 | 2020 | |
| Chiesi USA, INC. | $17.12 | 2022 | |
| Vifor Pharma, INC. | $12.39 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.